货号:A783435
同义名:
盐酸多塞平 (异构体混合物)
/ Doxepin (hydrochloride); Doxepin Hydrochloride
Doxepin hydrochloride 是一种具有口服活性的三环类抗抑郁剂,具有多种生物活性。它是一种高选择性的组胺 H1 受体拮抗剂(Kd = 310 pM),并对 H4 受体也有拮抗作用(pKi = 6.79)。此外,Doxepin 可抑制多种 CYP450 酶,尤其是 CYP2C19 和 CYP1A2,并能阻断血清素和去甲肾上腺素的再摄取。该化合物在特应性皮炎、慢性荨麻疹、神经保护及抗氧化应激等研究领域中具有广泛应用价值。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2[3]. Doxepin hydrochloride is an orally active tricyclic antidepressant agent[4]. In addition, intrathecally administered doxepin, like bupivacaine and lidocaine, produced dose-related spinal anesthetic effects on motor activity, proprioception, and nociception. Doxepin produced spinal anesthetic effects in rats more potent than that of lidocaine and longer than that of bupivacaine and lidocaine[5]. Doxepin displayed a very high affinity for H1 histamine receptor, being 8-fold more potent than mepyramine. Doxepin showed significant H2 blocking activity which was 5 times less potent than that of cimetidine. Doxepin competitively antagonized carbachol in the guinea pig ileum, and was 107 times less potent than atropine[6]. In PC3 cells, doxepin induced a [Ca²⁺](i) rise by evoking PLC-independent Ca²⁺ release from stores including the endoplasmic reticulum and Ca²⁺ entry via PKC-sensitive store-operated Ca²⁺ channels. Doxepin caused cell death that was independent of [Ca²⁺](i) rises[7]. |
| Concentration | Treated Time | Description | References | |
| Primary mouse hepatocytes | 30 μmol/L | 48 hours | Doxepin upregulated FAM3A expression, induced Akt phosphorylation, and suppressed gluconeogenic gene expression. | Diabetes. 2020 Jun;69(6):1126-1139 |
| HepG2 cells | 30 μmol/L | 48 hours | Doxepin induced FAM3A expression to suppress gluconeogenesis and lipogenesis. | Diabetes. 2020 Jun;69(6):1126-1139 |
| Administration | Dosage | Frequency | Description | References | ||
| Obese diabetic mice | High-fat diet-induced obese diabetic mouse model | Intraperitoneal injection | 5 or 10 mg/kg body weight | Once daily for 4 weeks | Doxepin ameliorated hyperglycemia, steatosis, and obesity, and upregulated FAM3A expression in liver and brown adipose tissues. | Diabetes. 2020 Jun;69(6):1126-1139 |
| C57BL6/J mice | High-fat diet-induced obesity model | Oral gavage | 5 mg/kg/day | Once daily for eight weeks | To investigate the effects of Doxepin on renal damage, glucose intolerance, nonalcoholic fatty liver disease, and urinary chromium loss in obese mice. Results showed that Doxepin exacerbated renal injury, glucose intolerance, and fatty liver disease, and increased urinary chromium loss. | Pharmaceuticals (Basel). 2021 Mar 16;14(3):267 |
| ICR mice | Pentobarbital-induced sleep model | Oral | 30 mg/kg | Single administration | Evaluate the effect of Doxepin on pentobarbital-induced sleep, results showed that Doxepin significantly decreased sleep latency and increased sleep duration. | Nutrients. 2017 May 18;9(5):512 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02191358 | - | Completed | - | United States, California ... 展开 >> Dr. Michael Dao Garden Grove, California, United States, 92844 United States, Colorado Kaiser Permanente Colorado Denver, Colorado, United States, 80011 United States, Kentucky Gill Heart Institute Lexington, Kentucky, United States, 40508 United States, Maryland IRC Clinics Towson, Maryland, United States, 21204 United States, Massachusetts Internal Medicine & Cardiology Associates Fall River, Massachusetts, United States, 02720 Prima CARE Fall River, Massachusetts, United States, 02720 United States, Virginia Carilion Clinic Christiansburg, Virginia, United States, 24073 收起 << | |
| NCT02374567 | Dementia Depr... 展开 >>ession Schizophrenia Psychosomatic Disorders Anxiety Disorders 收起 << | Phase 3 | Terminated | - | Germany ... 展开 >> Bezirkskrankenhaus Augsburg Augsburg, Germany Krankenhaus Hedwigshöhe Berlin, Germany Hannover Medical School Hannover, Germany, 30625 Asklepios Fachklinikum Lübben Lübben, Germany Asklepios Fachklinikum Teupitz Teupitz, Germany 收起 << |
| NCT02297126 | Adverse Drug Reaction | Not Applicable | Completed | - | United States, Indiana ... 展开 >> Eskenazi Health System Indianapolis, Indiana, United States, 46250 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.17mL 0.63mL 0.32mL |
15.83mL 3.17mL 1.58mL |
31.66mL 6.33mL 3.17mL |
|
| CAS号 | 1229-29-4 |
| 分子式 | C19H22ClNO |
| 分子量 | 315.84 |
| SMILES Code | CN(C)CC/C=C1C2=CC=CC=C2OCC3=CC=CC=C/13.Cl |
| MDL No. | MFCD00079135 |
| 别名 | 盐酸多塞平 (异构体混合物) ;Doxepin (hydrochloride); Doxepin Hydrochloride |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, room temperature |
| 溶解方案 |
DMSO: 105 mg/mL(332.45 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 50 mg/mL(158.31 mM) 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1